Norgine Partners With Noventure to Commercialise GELSECTAN® in Spain, Portugal and Andorra

LONDON, March 6, 2017 /PRNewswire/ --





Norgine B.V. announced today that it has entered into an agreement with Noventure S.L., under which Norgine will distribute GELSECTAN(R) in Spain, Portugal and Andorra.

(Logo: http://photos.prnewswire.com/prnh/20130829/633895-a)



GELSECTAN(R) is a Class IIa CE marked medical device used as a treatment for irritable bowel syndrome (IBS) with diarrhoea. Diarrhoea is one of the symptoms often associated with irritable bowel syndrome. GELSECTAN(R) is available in capsules for oral use.

IBS affects up to 7.8% of the total Iberian population (Spain, Portugal and Andorra) and more than 100,000 new cases are reported every year.[i] Women are twice likely as men to develop IBS.[ii]

Peter Martin, COO at Norgine said: "We are delighted to be able to offer GELSECTAN(R), a new treatment option to patients who suffer from irritable bowel syndrome (IBS) associated with diarrhoea, a condition which can have a significant impact on quality of life."

He added: "This recent partnership demonstrates our commitment to sell further specialised innovative products through our well established infrastructure."

Luciano Conde, CEO of Noventure, said: "GELSECTAN(R) is an innovative product that will help to improve the lives of patients across the Iberian Peninsula. We are delighted to partner with Norgine, a recognised leader in the treatment of gastrointestinal diseases with a well-established presence in Spain and Portugal."

Norgine anticipates launching GELSECTAN(R) in Iberia in the second half of 2017. Noventure will manufacture GELSECTAN(R).

Financial terms are not disclosed.

Access full media release on http://www.norgine.com

i. Miguel a Montoro. Gastroenterologia y hepatologia. Problemas comunes en la practica clinica. 2012

ii. Mearin et al. Med Clin (Barc.) 2007; 128 (9):335-43


 
Norgine Media Contacts: 
Isabelle Jouin, 
T: +44(0)1895-453643

 
Charlotte Andrews, 
T: +44(0)1895-453607 



 



Photo:
http://photos.prnewswire.com/prnh/20130829/633895-a




Norgine B.V.

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234